{
    "2019-12-23": [
        [
            {
                "time": "2018-01-03",
                "original_text": "Investors flock to neuro drug makers after FDA approves new schizophrenia drug",
                "features": {
                    "keywords": [
                        "FDA",
                        "schizophrenia drug",
                        "neuro drug makers"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false"
                }
            },
            {
                "time": "2018-01-04",
                "original_text": "Johnson & Johnson Stock Gets More Good News, but a Big Test Is On the Way",
                "features": {
                    "keywords": [
                        "Johnson & Johnson",
                        "good news",
                        "big test"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2018-01-05",
                "original_text": "GlaxoSmithKline's Long-Acting HIV Regimen Gets CRL From FDA",
                "features": {
                    "keywords": [
                        "GlaxoSmithKline",
                        "HIV regimen",
                        "CRL",
                        "FDA"
                    ],
                    "sentiment_score": -0.8,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "false"
                }
            },
            {
                "time": "2018-01-06",
                "original_text": "Johnson & Johnson Finally Shakes Off Its Bad News 'Overhang'",
                "features": {
                    "keywords": [
                        "Johnson & Johnson",
                        "bad news",
                        "overhang"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-01-07",
                "original_text": "Should iShares Russell Top 200 Value ETF (IWX) Be on Your Investing Radar?",
                "features": {
                    "keywords": [
                        "iShares",
                        "Russell Top 200 Value ETF",
                        "investing radar"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "ETFs",
                        "finance"
                    ],
                    "causal_factor": "false",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2018-01-08",
                "original_text": "After Moving Higher, Apple May Stop Bearing Fruit While It Corrects",
                "features": {
                    "keywords": [
                        "Apple",
                        "moving higher",
                        "correction"
                    ],
                    "sentiment_score": -0.5,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "technology"
                    ],
                    "causal_factor": "false",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2018-01-09",
                "original_text": "Wall Street Roundup: Analysts Make Moves on These 3 Stocks",
                "features": {
                    "keywords": [
                        "Wall Street",
                        "analysts",
                        "moves",
                        "stocks"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "finance"
                    ],
                    "causal_factor": "false",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}